Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Alain L. Fymat

Alain L. Fymat

Founding Chair, President/CEO and Professor
International Institute of Medicine & Science
USA

Biography

Dr. Alain L. Fymat, PhD, PhD is a medical-physical scientist and an educator who was educated at the Universities of Bordeaux and Paris-Sorbonne, France, and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, both Institutes located in California. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of the Radiology Service, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Charles R. Drew University of Medicine and Science in Los Angeles, California. He has extensively published (over 425 scholarly publications). He is Editor-in-Chief, Honorable Editor or Editor of 37 medical/scientific journals. His research interests are in nanomedicine (including oncology, chemotherapy, neurology, cardiology, and related nanobiotechnologies

Research Interest

nanomedicine including oncology, chemotherapy, neurology, cardiology, and related nanobiotechnologies.